| # | Title | Journal | Year | Citations |
|---|
| 1 | The size and burden of mental disorders and other disorders of the brain in Europe 2010 | European Neuropsychopharmacology | 2011 | 2,930 |
| 2 | Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States | International Journal of Methods in Psychiatric Research | 2012 | 2,042 |
| 3 | Anxiety and Anxiety Disorders in Children and Adolescents: Developmental Issues and Implications for DSM-V | Psychiatric Clinics of North America | 2009 | 1,165 |
| 4 | The economic cost of brain disorders in Europe | European Journal of Neurology | 2012 | 1,163 |
| 5 | Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS) | Psychological Medicine | 2004 | 1,006 |
| 6 | The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys | International Journal of Methods in Psychiatric Research | 2003 | 857 |
| 7 | Cost of disorders of the brain in Europe | European Journal of Neurology | 2005 | 714 |
| 8 | What do childhood anxiety disorders predict? | Journal of Child Psychology and Psychiatry and Allied Disciplines | 2007 | 599 |
| 9 | Generalized anxiety disorder: prevalence, burden, and cost to society | Depression and Anxiety | 2002 | 580 |
| 10 | Incidence of Social Anxiety Disorder and the Consistent Risk for Secondary Depression in the First Three Decades of Life | Archives of General Psychiatry | 2007 | 577 |
| 11 | Don’t fear ‘fear conditioning’: Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear | Neuroscience and Biobehavioral Reviews | 2017 | 543 |
| 12 | Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology | Journal of Psychopharmacology | 2014 | 511 |
| 13 | Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study | Lancet, The | 2019 | 498 |
| 14 | The economic costs of mental disorders | EMBO Reports | 2016 | 488 |
| 15 | Using screening tools to identify neuropathic pain | Pain | 2007 | 462 |
| 16 | Prevalence, incidence and stability of premenstrual dysphoric disorder in the community | Psychological Medicine | 2002 | 455 |
| 17 | Twelve‐month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1‐MH) | International Journal of Methods in Psychiatric Research | 2014 | 393 |
| 18 | Incidence and Risk Patterns of Anxiety and Depressive Disorders and Categorization of Generalized Anxiety Disorder | Archives of General Psychiatry | 2010 | 373 |
| 19 | Alcohol use in times of the COVID 19: Implications for monitoring and policy | Drug and Alcohol Review | 2020 | 347 |
| 20 | Anxiety disorders | Nature Reviews Disease Primers | 2017 | 345 |
| 21 | Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation? | Drug and Alcohol Dependence | 2009 | 317 |
| 22 | Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients | Journal of Affective Disorders | 2008 | 316 |
| 23 | Separating optimism and pessimism: A robust psychometric analysis of the Revised Life Orientation Test (LOT-R). | Psychological Assessment | 2006 | 312 |
| 24 | Mental Disorders and Asthma in the Community | Archives of General Psychiatry | 2003 | 308 |
| 25 | Epidemiology of Anxiety Disorders | Current Topics in Behavioral Neurosciences | 2009 | 275 |
| 26 | What predicts incident use of cannabis and progression to abuse and dependence? | Drug and Alcohol Dependence | 2002 | 253 |
| 27 | Risk factors and course patterns of anxiety and depressive disorders during pregnancy and after delivery: A prospective-longitudinal study | Journal of Affective Disorders | 2015 | 246 |
| 28 | Cognitive impairment in 873 patients with idiopathic Parkinson's disease | Journal of Neurology | 2008 | 242 |
| 29 | Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population | Social Psychiatry and Psychiatric Epidemiology | 2008 | 239 |
| 30 | Developmental Epidemiology of Anxiety Disorders | Child and Adolescent Psychiatric Clinics of North America | 2012 | 235 |
| 31 | Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey | International Clinical Psychopharmacology | 2000 | 234 |
| 32 | Common and Distinct Amygdala-Function Perturbations in Depressed vs Anxious Adolescents | Archives of General Psychiatry | 2009 | 232 |
| 33 | Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness–persistence model | Psychological Medicine | 2007 | 231 |
| 34 | Physical activity and prevalence and incidence of mental disorders in adolescents and young adults | Psychological Medicine | 2007 | 222 |
| 35 | Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V | Depression and Anxiety | 2010 | 218 |
| 36 | Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease | Journal of Neurology | 2010 | 216 |
| 37 | Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective | Journal of Behavioral Addictions | 2018 | 214 |
| 38 | Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication | Psychological Medicine | 2005 | 213 |
| 39 | Self‐reported utilization of mental health services in the adult German population – evidence for unmet needs? Results of the DEGS1‐Mental Health Module (DEGS1‐MH) | International Journal of Methods in Psychiatric Research | 2014 | 207 |
| 40 | Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V | Depression and Anxiety | 2010 | 197 |
| 41 | Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument | Parkinsonism and Related Disorders | 2008 | 191 |
| 42 | Structural plasticity of the social brain: Differential change after socio-affective and cognitive mental training | Science Advances | 2017 | 184 |
| 43 | How Common is Men's Self-Reported Sexual Interest in Prepubescent Children? | Journal of Sex Research | 2016 | 182 |
| 44 | The clinical characterization of the adult patient with depression aimed at personalization of management | World Psychiatry | 2020 | 174 |
| 45 | Prevalence, incidence, and natural course of anorexia and bulimia nervosa among adolescents and young adults | European Child and Adolescent Psychiatry | 2016 | 168 |
| 46 | Psychodynamic Therapy: As Efficacious as Other Empirically Supported Treatments? A Meta-Analysis Testing Equivalence of Outcomes | American Journal of Psychiatry | 2017 | 168 |
| 47 | The natural course of cannabis use, abuse and dependence during the first decades of life | Addiction | 2008 | 162 |
| 48 | Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders | Psychological Medicine | 2013 | 161 |
| 49 | Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders | Psychopharmacology | 2015 | 159 |
| 50 | Neuropeptide S receptor gene — converging evidence for a role in panic disorder | Molecular Psychiatry | 2011 | 157 |
